Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Feb 6.
Published in final edited form as: Curr Diab Rep. 2017 Jun;17(6):36. doi: 10.1007/s11892-017-0869-0

Vascular and Endothelial Function in Youth with Type 2 Diabetes Mellitus

Amy S Shah 1,, Elaine M Urbina 2
PMCID: PMC5800521  NIHMSID: NIHMS938693  PMID: 28432570

Abstract

Purpose of Review

This review aims to discuss the burden of type 2 diabetes in youth and summarize the studies that have utilized noninvasive techniques to assess early vascular disease in youth with type 2 diabetes.

Recent Findings

Noninvasive imaging modalities provide researchers with tools to investigate the vasculature in adolescents with type 2 diabetes. The data published to date consistently show adolescents with type 2 diabetes have greater vascular thickness and stiffness and worse endothelial function compared to their obese and lean peers.

Summary

As the prevalence of type 2 diabetes continues to increase adolescent youth, there is concern adolescents with type 2 diabetes are at risk to develop early onset cardiovascular disease and complications. Future studies need to address treatments that have the potential to improve or reverse vascular dysfunction and decrease the rate of cardiovascular disease and complications.

Keywords: Adolescents, Type 2 diabetes, Vascular, Endothelial function, Carotid artery

Introduction

Type 2 diabetes (T2D) is associated with a 2–4 fold higher risk of developing myocardial infarction, stroke, neuropathy, blindness, and death [13]. T2D is also responsible for more cases of renal failure and peripheral vascular disease leading to amputation than any other diseases [4]. Furthermore, there is emerging evidence that T2D is associated with cognitive decline and dementia [510]. In 2010, the cost of care for diabetes and its complications in the USA was estimated to be greater than $316 billion per year and continues to rise [11].

Prior to 1992, T2D was considered an adult disease. However, in parallel with increases in the rate of childhood obesity, type 2 diabetes has now emerged as a formidable threat to the health of adolescents [12]. T2D accounts for nearly 50% of new diabetes cases in adolescents and the incidence and prevalence continue to rise [1316]. Data from The SEARCH for Diabetes in Youth study estimates that 20,000 youth currently have T2D [14] but by 2050 this number will quadruple [17]. Similar findings have been seen across the globe in the UK, Japan, and India, where T2D is diagnosed twice as often as type 1 diabetes (T1D) among adolescents [1820]. As the age of T2D on set has decreased [21], there is a growing concern that complications, traditionally seen in adults, will manifest by early adulthood [22].

A Canadian registry reported that complications, including dialysis, blindness, and amputation occur within 10 years of adolescent T2D diagnosis and youth with T2D are six times more likely to develop cardiovascular disease (compared to peers without T2D) [23••]. Furthermore, rates of complications, including cardiovascular death, are higher in adolescent onset T2D than in T1D despite less severe hyperglycemia, virtually no hypoglycemia, and relatively short disease duration [24, 25]. These findings suggest adolescents with T2D are at accelerated risk to develop target organ damage and many will develop marked comorbidity by early adulthood [26••].

This increased cardiovascular disease risk in youth with T2D has led to the critical need to employ tools that can assess early vascular disease. As a result, well-established noninvasive modalities, previously limited to use in adults [2731] are now being used in adolescents to detect early vascular changes, reflected by an increase in vessel thickness and stiffness. Below, we describe some of the most widely used imaging modalities in pediatrics and summarize the studies that have been used to assess the effects of T2D on early cardiovascular disease (Table 1).

Table 1.

Noninvasive imaging methods

Technique Method Device Variable unit What does it measure? Studies in youth with type 2 diabetes
Carotid thickness
 Carotid intima Media thickness B mode ultrasound Ultrasound with linear array transducer mm Thickness of the intima media layer of the carotid artery either in the common carotid, bulb carotid, or internal carotid Ref. [3236]
Carotid stiffness
 Young’s elastic modulus, Beta stiffness index M mode Ultrasound Ultrasound with linear array transducer YEM (mm Hg/mm); beta (unitless) Stiffness in the carotid artery Ref. [33]
Arterial stiffness
 Brachial distensibility Oscillmetric systolic/diastolic blood pressure Pulsemetric DynaPulse %change/mmHg Resting distensibility of the medium muscular artery in the arm. Lower is worse Ref. [44, 47]
 Pulse wave velocity Applanation tonometry AtCor SphygmoCor m/s Speed of pulse wave along an arterial segment Ref. [44, 47]
 Augmentation index Applanation tonometry AtCor SphygmoCor % Increase in central systolic pressure due to reflected wave as a percentage of central pulse pressure Ref. [44, 47]
Endothelial function
 Brachial artery flow mediated dilation Ultrasound Ultrasound FMD max (%) FMD max is maximum % change at any time period post occlusion (30 to 120 s) Ref. [34, 52, 55•]
 Peripheral arterial tonometry EndoPat Itamar % Increase in blood flow in the digit after release of occlusion normalized to the control finger No published studies
 Microvascular endothelial function Laser Doppler Perimed Perfusion units Change in perfusion units after heating No published studies

Carotid Intima Media Thickness

In adults, a higher carotid intima media thickness (IMT) predicts the development of future cardiovascular events, including stroke and myocardial infarction [2729]. As such, carotid IMT is one of the more powerful tools to assess early atherosclerosis. Carotid IMT is measured using high-resolution B-mode ultrasonography and a high frequency transducer. The far wall intima-media layer of the blood vessel in either the common carotid, internal carotid, or bulb (bifurcation) is imaged and can be quantitated (Fig. 1).

Fig. 1.

Fig. 1

a Ultrasound image taken from the carotid artery demonstrating the intima-medial layer. The intimal-medial thickness is measured (in mm) from the border between the echolucent vessel lumen and the echogenic intima (white arrow) and the border between the echolucent media and echogenic adventitia (red arrow). Also shown is Meyer’s arc device can be used to record angle of insonation when measuring carotid intima-media thickness measurements. b Horizontal 2-D image of carotid artery with the M mode cursor placed in the common carotid. Minimal and maximal artery diameters are measured to calculate carotid stiffness

Studies conducted in the USA and Australia demonstrate that adolescents with T2D have higher carotid IMT compared to their obese and lean peers [3234] with group differences detected as early as 14 years of age [32]. Specifically, data from our center shows that adolescents with type 2 diabetes (N = 237) have higher carotid IMT in all segments of the carotid artery (common carotid, internal carotid, and bulb carotid, Fig. 2) compared to lean (n = 273) and obese youth (n = 252). Risk factors associated with a higher carotid IMT include poorer glucose control (hemoglobin A1c), longer duration of disease, and greater insulin resistance [32]. Shah et al. reported that each 1% increase in hemoglobin A1c or each year increase in duration of T2D was associated with approximately 30% increased odds of a thicker carotid IMT [35]. Studies also show higher body mass index, higher blood pressure [32], and lower HDL cholesterol levels [36] are associated with a thicker carotid. Longitudinal data have not yet been published, but are expected soon, as our group is concluding a long-term follow-up study. We studied 226 adolescents at baseline and 4.6 years later (initial age 16.6 years, 37% Caucasian and 40% male). Briefly, while IMT appears unchanged in the lean group from baseline to follow-up, there is an increase in carotid IMT for both obese youth and those with T2D, with a slope that is significantly different compared to lean (p < 0.05).

Fig. 2.

Fig. 2

Mean carotid intima media thickness in the common carotid, bulb, and internal carotid arteries from lean (n = 273), obese (n = 252), and adolescents with type 2 diabetes (n = 237) studied in Cincinnati, Ohio. Mean age 18 years, 41% white, 35% male. Values shown in millimeters where * indicates T2D > lean and obese at p < 0.05; ** indicates T2D > obese > lean at p < 0.05

Carotid Stiffness

By switching to M mode on the carotid ultrasound image, stiffness of the carotid artery can be assessed. Calculations of carotid stiffness included incremental elastic modulus (Einc) [37], Peterson mean pressure-strain elastic modulus (PEM), Young’s elastic modulus (YEM), and beta arterial stiffness index (beta stiffness) [38]. Fewer studies using these measurements have been performed in youth with T2D. Urbina et al. reported higher beta stiffness and YEM in youth with T2D compared to lean youth, but no differences compared to obese controls [33]. PEM and Einc were not reported. Multivariate modeling found higher body mass index and blood pressure were associated with a higher YEM and beta stiffness after adjusting for age, race, and sex [33]. Similar findings have been reported in adults, where higher carotid stiffness has been observed in participants with T2D compared to controls. In adults, greater insulin resistance, hyper-glycemia and triglyceride levels have also been associated with greater carotid stiffness [39, 40].

Arterial Stiffness

In addition to imaging the carotid artery, assessment of peripheral artery mechanics can be helpful in predicting cardiovascular risk [31]. Two commonly used measures of arterial stiffness include pulse wave velocity (PWV) and augmentation index (AIx). PWV is a derived gradient velocity calculated from noninvasive pulse waveforms at two separate peripheral sites (most commonly the carotid and femoral arteries) and the distance between them, where a greater PWV indicates higher arterial stiffness. AIx is derived from pulse waveforms at a single arterial site, calculated as the difference in the augmented and forward waves in an arterial waveform, divided by the overall pulse pressure of the waveform, where a higher AIx is a proxy of greater stiffness. In adults, PWV predicts degree of arterial plaque [41] and future cardiovascular disease mortality and is considered the gold standard measurement of arterial stiffness [42]. Brachial distensibility (BrachD) is another reproducible [43] and validated noninvasive measure of arterial stiffness [30] that has been linked to the development and progression of atherosclerotic vascular disease in adults. BrachD assesses resting vascular function in a medium muscular artery [26••] and is derived from pressure curves generated from arterial pressure signals obtained from a standard blood pressure cuff sphygmomanometer. A lower BrachD indicates increased vascular stiffness.

Only one large study (n = 670) has been conducted in youth evaluating arterial stiffness in adolescents with T2D compared to lean and obese controls. Using all three measures described above, Urbina et al. found that adolescents with T2D (mean age 18 years) with diabetes for less than 4 years had higher PWV and AIX and lower BrachD compared to normal weight and obese youth [44]. In multivariate regression models, obesity was an independent predictor of PWV and BrachD (but not AIx) after adjustment for risk factors [44]. Further work from the same group showed that both PWV and AIx are higher in non-Hispanic Black compared to non-Hispanic White youth with T2D [45], and lower BrachD is evident in the vasculature before the onset of T2D diabetes, specifically in youth with pre-diabetes [46]. Recently, Li et al. showed that inflammation may also be a risk factor for increased arterial stiffness. Their group compared arterial stiffness in adolescents with recent onset T2D. Compared to those with no inflammation, those with low grade inflammation, defined as a high-sensitivity C-reactive concentration of >2 mg/dL, had a higher PWV, AIx and lower BrachD. Furthermore, C-reactive protein concentration was an independent determinant of each of the arterial stiffness measurements [47].

Endothelial Function

Alteration in the vascular endothelium is another means to assess the health of the arteries. Flow mediated dilation (FMD) has been used most commonly in adolescent studies [48, 49]. As currently measured, the brachial artery is briefly occluded by a pneumatic cuff and released. Dilation of the distal artery normally occurs and the resultant increased blood flow and diameter are assessed by ultrasound [50]. The percent change in flow after ischemic stress is called FMD. The brachial artery typically dilates 6–12% in healthy people [48, 49] and diminution of the response is termed endothelial dysfunction. Endothelial dysfunction is associated with the cardiovascular disease risk factors and coronary artery atherosclerosis in adults [51].

Only recently have the results of two endothelial function studies in youth with T2D been published. Naylor et al. reported that adolescents with T2D have lower brachial FMD compared to normal weight (but not obese) controls [34]. Ohsugi et al. found that adolescents with T2D have lower brachial FMD than youth with T1D [52]. Lower BrachD in the T2D group occurred despite both groups having similar hemoglobin A1c levels and youth with T2D having a shorter diabetes duration [52]. These initial findings suggest that obesity and/or insulin resistance may be an important risk factor associated with endothelial dysfunction. Indeed, several studies have also shown overweight and obese children with insulin resistance show reduced FMD compared with control subjects when matched for blood pressure, cholesterol, and glucose levels [53].

Endothelial function can also be assessed by peripheral arterial tonometry (Endo-PAT) where probes are placed on one finger of each hand (one finger is the test, the other is the control) and pulsatile signals are recorded. A blood pressure cuff is then inflated to occlude blood flow and the response after deflation is recorded as the reactive hyperemia index, which correlates with the coronary blood flow response to acetylcholine at cardiac catheterization [54]. In unpublished work from our center, we evaluated endothelial function using Endo-PAT in 379 adolescents and young adults (mean age 23 years) who were lean, obese, or had T2D. We found no differences by group but observed an inverse correlation between A1c and reactive hyperemia index. This finding was confirmed using laser flow Doppler in this same group of adolescents. Laser flow Doppler uses a probe placed on the finger to assess endothelial function or microvascular perfusion. Similar to above, after release of a blood pressure cuff, post occlusion reactive hyperemia (PORH) is measured. The baseline perfusion is subtracted from the peak perfusion and is expressed as a percent. At our center, we observed an inverse association between A1c and PORH in lean, obese, and T2D youth. These findings suggest that glucose control may be important for endothelial function, at least in young adults.

There are emerging data suggesting that endothelial function can improve in youth with T2D. Eight youth with T2D participated in a supervised exercise training program for 12 weeks. Youth who exercised had improvement in brachial FMD compared to five youth with no exercise [55•]. These changes occurred without significant changes in BMI, suggesting that physical activity, even without weight loss, may improve vascular heath in adolescents with T2D. Additional larger scale studies are needed to confirm these results.

Gaps and Limitations

Despite the wide use of noninvasive imaging modalities in the pediatric research setting, there are limitations of the methods that should be discussed. First, except for a few small pediatric validation studies of PWV [56], AIx [57], and endothelial function measured by Endo-PAT [54], none of the remaining imaging modalities have been validated specifically in this age group. However, there is no reason to believe that the experiments proving that simultaneous noninvasive measurements correlated with intra-arterial measurements in adults would not apply equally to children, particularly those who are essentially of adult size [31, 58]. Second, there is lack of normative data by age, race, and sex. While several studies have included data on larger numbers of healthy youth, nicely reviewed here [59••], there is lack of consistency among techniques so the “normal” values must be interpreted only for the specific device used. Finally, large-scale longitudinal and intervention studies have not been reported yet, therefore it is unclear how carotid and arterial thickness and stiffness progress overtime and whether lifestyle or T2D treatments have the potential to improve or reverse thickness and stiffness and, eventually, decrease the rate of cardiovascular disease and complications.

Conclusions

Noninvasive imaging modalities have provided researchers with tools to investigate the vasculature in high risk populations, with the data to date consistently showing that youth with T2D have greater vascular thickness and stiffness compared to their peers. While there is insufficient evidence at this time to recommend the use of any of these methods in routine clinical care, there are sufficient data to show these tools provide valuable information and can be used reliably when utilized in youth with T2D.

Footnotes

Compliance with Ethical Standards

Conflict of Interest Amy S. Shah and Elaine M. Urbina declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent This article contains some unpublished data. All data was obtained after obtained informed consent in accordance with local institutional review board policy.

References

Papers of particular interest, published recently, have been highlighted as:

• Of importance

•• Of major importance

  • 1.Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241(19):2035–8. doi: 10.1001/jama.241.19.2035. [DOI] [PubMed] [Google Scholar]
  • 2.Palumbo PJ, et al. Diabetes mellitus: incidence, prevalence, survivorship, and causes of death in Rochester, Minnesota, 1945–1970. Diabetes. 1976;25(7):566–73. doi: 10.2337/diab.25.7.566. [DOI] [PubMed] [Google Scholar]
  • 3.Gregg EW, et al. Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey. Diabetes Care. 2012;35(6):1252–7. doi: 10.2337/dc11-1162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Nathan DM. Clinical practice. Initial management of glycemia in type 2 diabetes mellitus. N Engl J Med. 2002;347(17):1342–9. doi: 10.1056/NEJMcp021106. [DOI] [PubMed] [Google Scholar]
  • 5.Biessels GJ, et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5(1):64–74. doi: 10.1016/S1474-4422(05)70284-2. [DOI] [PubMed] [Google Scholar]
  • 6.Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies. Diabetologia. 2005;48(12):2460–9. doi: 10.1007/s00125-005-0023-4. [DOI] [PubMed] [Google Scholar]
  • 7.Stewart R, Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med. 1999;16(2):93–112. doi: 10.1046/j.1464-5491.1999.00027.x. [DOI] [PubMed] [Google Scholar]
  • 8.van Elderen SG, et al. Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up. Neurology. 2010;75(11):997–1002. doi: 10.1212/WNL.0b013e3181f25f06. [DOI] [PubMed] [Google Scholar]
  • 9.Ott A, et al. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology. 1999;53(9):1937–42. doi: 10.1212/wnl.53.9.1937. [DOI] [PubMed] [Google Scholar]
  • 10.Ruis C, et al. Cognition in the early stage of type 2 diabetes. Diabetes Care. 2009;32(7):1261–5. doi: 10.2337/dc08-2143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Mayer-Davis EJ, et al. Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: implications of a factor analysis of clustering. Metab Syndr Relat Disord. 2009;7(2):89–95. doi: 10.1089/met.2008.0046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Hannon TS, Arslanian SA. The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes. Ann N YAcad Sci. 2015;1353:113–37. doi: 10.1111/nyas.12939. [DOI] [PubMed] [Google Scholar]
  • 13.Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr. 2005;146(5):693–700. doi: 10.1016/j.jpeds.2004.12.042. [DOI] [PubMed] [Google Scholar]
  • 14.Dabelea D, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014;311(17):1778–86. doi: 10.1001/jama.2014.3201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Copeland KC, et al. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metab. 2011;96(1):159–67. doi: 10.1210/jc.2010-1642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Pinhas-Hamiel O, et al. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr. 1996;128(5 Pt 1):608–15. doi: 10.1016/s0022-3476(96)80124-7. [DOI] [PubMed] [Google Scholar]
  • 17.Imperatore G, et al. Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care. 2012;35(12):2515–20. doi: 10.2337/dc12-0669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Amutha A, et al. Clinical profile of diabetes in the young seen between 1992 and 2009 at a specialist diabetes centre in south India. Prim Care Diabetes. 2011;5(4):223–9. doi: 10.1016/j.pcd.2011.04.003. [DOI] [PubMed] [Google Scholar]
  • 19.Urakami T, et al. Screening and treatment of childhood type 1 and type 2 diabetes mellitus in Japan. Pediatr Endocrinol Rev. 2012;10(Suppl 1):51–61. [PubMed] [Google Scholar]
  • 20.Ehtisham S, Barrett TG, Shaw NJ. Type 2 diabetes mellitus in UK children–an emerging problem. Diabet Med. 2000;17(12):867–71. doi: 10.1046/j.1464-5491.2000.00409.x. [DOI] [PubMed] [Google Scholar]
  • 21.Dabelea D, et al. Increasing prevalence of type II diabetes in American Indian children. Diabetologia. 1998;41(8):904–10. doi: 10.1007/s001250051006. [DOI] [PubMed] [Google Scholar]
  • 22.Kavey RE, et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association expert panel on population and prevention science; the councils on cardiovascular disease in the young, epidemiology and prevention, nutrition, physical activity and metabolism, high blood pressure research, cardiovascular nursing, and the kidney in heart disease; and the interdisciplinary working group on quality of care and outcomes research. J Cardiovasc Nurs. 2007;22(3):218–53. doi: 10.1097/01.JCN.0000267827.50320.85. [DOI] [PubMed] [Google Scholar]
  • 23••.Dart AB, et al. Earlier onset of complications in youth with type 2 diabetes. Diabetes Care. 2014;37(2):436–43. doi: 10.2337/dc13-0954. This study provides an update on rates of complications in adolescent type 2 diabetes compared to adolescent type 1 diabetes and controls without diabetes. [DOI] [PubMed] [Google Scholar]
  • 24.Constantino MI, et al. Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes. Diabetes Care. 2013;36(12):3863–9. doi: 10.2337/dc12-2455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Eppens MC, et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care. 2006;29(6):1300–6. doi: 10.2337/dc05-2470. [DOI] [PubMed] [Google Scholar]
  • 26••.Maahs DM, et al. Cardiovascular disease risk factors in youth with diabetes mellitus: a scientific statement from the american heart association. Circulation. 2014;130(17):1532–58. doi: 10.1161/CIR.0000000000000094. This study provides a thorough review of the current research on cardiovascular risk factors in youth with type 2 diabetes. [DOI] [PubMed] [Google Scholar]
  • 27.Chambless LE, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis isk in Communities (ARIC) Study, 1987–1993. Am J Epidemiol. 1997;146(6):483–94. doi: 10.1093/oxfordjournals.aje.a009302. [DOI] [PubMed] [Google Scholar]
  • 28.O’Leary DH, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999;340(1):14–22. doi: 10.1056/NEJM199901073400103. [DOI] [PubMed] [Google Scholar]
  • 29.Simons PC, et al. Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART study (second manifestations of ARTerial disease) Circulation. 1999;100(9):951–7. doi: 10.1161/01.cir.100.9.951. [DOI] [PubMed] [Google Scholar]
  • 30.Brinton TJ, et al. Development and validation of a noninvasive method to determine arterial pressure and vascular compliance. Am J Cardiol. 1997;80(3):323–30. doi: 10.1016/s0002-9149(97)00353-6. [DOI] [PubMed] [Google Scholar]
  • 31.Laurent S, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27(21):2588–605. doi: 10.1093/eurheartj/ehl254. [DOI] [PubMed] [Google Scholar]
  • 32.Kotb NA, et al. Clinical and biochemical predictors of increased carotid intima-media thickness in overweight and obese adolescents with type 2 diabetes. Diab Vasc Dis Res. 2012;9(1):35–41. doi: 10.1177/1479164111421804. [DOI] [PubMed] [Google Scholar]
  • 33.Urbina EM, et al. Youth with obesity and obesity-related type 2 diabetes mellitus demonstrate abnormalities in carotid structure and function. Circulation. 2009;119(22):2913–9. doi: 10.1161/CIRCULATIONAHA.108.830380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Naylor LH, et al. Endothelial function and carotid intima-medial thickness in adolescents with type 2 diabetes mellitus. J Pediatr. 2011;159(6):971–4. doi: 10.1016/j.jpeds.2011.05.019. [DOI] [PubMed] [Google Scholar]
  • 35.Shah AS, et al. Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2009;94(10):3740–5. doi: 10.1210/jc.2008-2039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Shah AS, et al. Lipids and lipoprotein ratios: contribution to carotid intima media thickness in adolescents and young adults with type 2 diabetes mellitus. J Clin Lipidol. 2013;7(5):441–5. doi: 10.1016/j.jacl.2013.05.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Gosling RG, Budge MM. Terminology for describing the elastic behavior of arteries. Hypertension. 2003;41(6):1180–2. doi: 10.1161/01.HYP.0000072271.36866.2A. [DOI] [PubMed] [Google Scholar]
  • 38.Cavallini MC, Roman MJ, Blank SG, Pini R, Pickering TG, Devereux RB. Association of the auscultatory gap with vascular disease in hypertensive patients. Ann Intern Med. 1996;124(10):877–83. doi: 10.7326/0003-4819-124-10-199605150-00003. [DOI] [PubMed] [Google Scholar]
  • 39.Salomaa V, et al. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC study. Atherosclerosis risk in communities study. Circulation. 1995;91(5):1432–43. doi: 10.1161/01.cir.91.5.1432. [DOI] [PubMed] [Google Scholar]
  • 40.van Dijk RA, et al. Associations of metabolic variables with arterial stiffness in type 2 diabetes mellitus: focus on insulin sensitivity and postprandial triglyceridaemia. Eur J Clin Investig. 2003;33(4):307–15. doi: 10.1046/j.1365-2362.2003.01137.x. [DOI] [PubMed] [Google Scholar]
  • 41.McLeod AL, et al. Non-invasive measures of pulse wave velocity correlate with coronary arterial plaque load in humans. J Hypertens. 2004;22(2):363–8. doi: 10.1097/00004872-200402000-00021. [DOI] [PubMed] [Google Scholar]
  • 42.Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(13):1318–27. doi: 10.1016/j.jacc.2009.10.061. [DOI] [PubMed] [Google Scholar]
  • 43.Urbina EM, et al. Brachial artery distensibility and relation to cardiovascular risk factors in healthy young adults (The Bogalusa Heart Study) Am J Cardiol. 2002;89(8):946–51. doi: 10.1016/s0002-9149(02)02244-0. [DOI] [PubMed] [Google Scholar]
  • 44.Urbina EM, et al. Increased arterial stiffness is found in adolescents with obesity or obesity-related type 2 diabetes mellitus. J Hypertens. 2010;28(8):1692–8. doi: 10.1097/HJH.0b013e32833a6132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Shah AS, et al. Racial differences in arterial stiffness among adolescents and young adults with type 2 diabetes. Pediatr Diabetes. 2012;13(2):170–5. doi: 10.1111/j.1399-5448.2011.00798.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Shah AS, et al. Prediabetes: the effects on arterial thickness and stiffness in obese youth. J Clin Endocrinol Metab. 2014;99(3):1037–43. doi: 10.1210/jc.2013-3519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Li X, et al. Low-grade inflammation and increased arterial stiffness in Chinese youth and adolescents with newly-diagnosed type 2 diabetes mellitus. J Clin Res Pediatr Endocrinol. 2015;7(4):268–73. doi: 10.4274/jcrpe.2187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Skilton MR, Celermajer DS. Endothelial dysfunction and arterial abnormalities in childhood obesity. Int J Obes. 2006;30(7):1041–9. doi: 10.1038/sj.ijo.0803397. [DOI] [PubMed] [Google Scholar]
  • 49.Corretti MC, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39(2):257–65. doi: 10.1016/s0735-1097(01)01746-6. [DOI] [PubMed] [Google Scholar]
  • 50.Deanfield J, et al. Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23(1):7–17. doi: 10.1097/00004872-200501000-00004. [DOI] [PubMed] [Google Scholar]
  • 51.Cox DA, et al. Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans. Circulation. 1989;80(3):458–65. doi: 10.1161/01.cir.80.3.458. [DOI] [PubMed] [Google Scholar]
  • 52.Ohsugi K, et al. Comparison of brachial artery flow-mediated dilation in youth with type 1 and type 2 diabetes mellitus. J Diabetes Investig. 2014;5(5):615–20. doi: 10.1111/jdi.12191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Woo KS, et al. Overweight in children is associated with arterial endothelial dysfunction and intima-media thickening. Int J Obes Relat Metab Disord. 2004;28(7):852–7. doi: 10.1038/sj.ijo.0802539. [DOI] [PubMed] [Google Scholar]
  • 54.Bonetti PO, et al. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol. 2004;44(11):2137–41. doi: 10.1016/j.jacc.2004.08.062. [DOI] [PubMed] [Google Scholar]
  • 55•.Naylor LH, et al. Exercise training improves vascular function in adolescents with type 2 diabetes. Physiol Rep. 2016;4(4):e12713. doi: 10.14814/phy2.12713. This article shows exercise trainings are associated with improvements in vascular function. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Seki M, et al. Aortic stiffness and aortic dilation in infants and children with tetralogy of Fallot before corrective surgery: evidence for intrinsically abnormal aortic mechanical property. Eur J Cardiothorac Surg. 2012;41(2):277–82. doi: 10.1016/j.ejcts.2011.05.024. [DOI] [PubMed] [Google Scholar]
  • 57.Urbina EM, et al. Relationship between elevated arterial stiffness and increased left ventricular mass in adolescents and young adults. J Pediatr. 2011;158(5):715–21. doi: 10.1016/j.jpeds.2010.12.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.O’Rourke MF, Gallagher DE. Pulse wave analysis. J Hypertens Suppl. 1996;14(5):S147–57. [PubMed] [Google Scholar]
  • 59••.Townsend RR, et al. Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association. Hypertension. 2015;66(3):698–722. doi: 10.1161/HYP.0000000000000033. This article summarizes current recommendations for improving and standardizing the use of noninvasive imaging techniques. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES